v3.26.1
Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Summary of Common Shares Outstanding
The following table summarizes issuance, repurchase, and other activity with respect to the Company's common stock for the three-month periods ended March 31, 2026 and 2025:
Three-Month Period Ended
March 31, 2026March 31, 2025
Shares of Common Stock Outstanding—Beginning Balance113,138,860 90,678,492 
Share Activity:
Shares of common stock issued11,510,163 3,750,388 
Shares of Common Stock Outstanding—Ending Balance124,649,023 94,428,880 
Dividends Declared
The following table summarizes cash dividends accrued by the Company on its common and preferred stock during the three-month periods ended March 31, 2026 and 2025:
(In thousands, except per share amounts)Three-Month Period Ended March 31,
20262025
Class of StockAmountPer ShareAmountPer Share
Series A Preferred Stock$1,678 $0.36 $2,830 $0.61 
Series B Preferred Stock1,883 0.39 1,883 0.39 
Series C Preferred Stock2,156 0.54 2,156 0.54 
Series D Preferred Stock166 0.44 166 0.44 
Common Stock49,137 0.39 36,232 0.39 
Restricted Shares - Vesting Period
The below table details unvested restricted common stock as of March 31, 2026:
Grant RecipientNumber of Shares of Unvested Restricted Common StockGrant Date
Vesting Date(1)
Directors:
18,396 September 10, 2025September 9, 2026
Total unvested restricted shares of common stock at March 31, 202618,396 
(1)Date at which such common shares will vest and become non-forfeitable.